New merger guidelines would consider competition, market concentration
By
Kathleen Steele Gaivin
Jul 24, 2023
New merger guidelines proposed by the Federal Trade Commission and the Department of Justice are meant to consider the intricacies of the modern economy, such mergers that are part of a series of multiple...
Composite inflammatory biomarker linked to dementia risk
Jul 21, 2023
Small but significant associations were seen between elevated biomarker levels and worsened cognitive performance.
Despite benefits of senior living, independence fuels desire to age in place
By
Kimberly Bonvissuto
Jul 21, 2023
A desire to remain independent is the main driver for prospective senior living residents who say they would rather age in place in their homes than move into a congregate living setting, according to...
Welltower makes ‘transformational strides’ in ESG initiatives: report
By
Kathleen Steele Gaivin
Jul 21, 2023
Toledo, OH-based Welltower experienced a year of “significant achievement” across many environmental, social and governance categories, according to the real estate investment trust’s annual ESG...
Eight in 10 seniors see wisdom of dementia screening
Jul 20, 2023
Only about one in five has had such screening in the past year, however.
Residence in disadvantaged neighborhoods increases dementia risk
Jul 20, 2023
Older veterans living in more disadvantaged neighborhoods have an increased risk for dementia in an adjusted analyses.
Staffing challenges need attention from federal policymakers, industry advocates say
By
Kimberly Bonvissuto
Jul 20, 2023
Healthcare workforce shortages are at crisis levels and need attention from policymakers, according to senior living advocates.
Decline in cognitive functioning after retirement varies by race, sex
Jul 19, 2023
The study finds that declines are steeper for white versus Black retirees and for men versus and women.
Solanezumab does not slow cognitive decline in preclinical Alzheimer’s disease
Jul 19, 2023
The mean change in Preclinical Alzheimer Cognitive Composite score not significantly different at 240 weeks with solanezumab or placebo.
ChatGPT can mimic clinicians for ‘low-risk’ queries, study finds
By
Aaron Dorman
Jul 19, 2023
A recent study on AI’s capabilities in healthcare suggests that patients are willing to receive advice from chatbots on “low-risk” topics.